Alto Neuroscience Inc. (NYSE:ANRO) currently has a daily average trading volume of 615.17K but it saw 16354289 shares traded in last market. With a market cap of 117.55M USD, the company’s current market price of $4.36 came falling about -69.99 while comparing to the previous closing price of $14.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $24.00 and as low as $7.91. In the recent trading on the day, stock has struck highest price mark of $4.2605 while lowest mark touched by it was $5.73.
Taking a look at 20-day trading activity of Alto Neuroscience Inc. (ANRO) gives us an average price of $12.03, while its current price level is -81.83% below from 52-week high level whereas it is -44.88% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $12.16. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.36% during that period while stretching the period over a month that decreases to 7.87%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 22.18 which implies that the stock is in oversold territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wedbush which downgraded the stock as “Neutral” in its note to investors issued on October 23, 2024, recommending a price target of between $29 and $4 for it. Wedbush issued its recommendations for the stock as it initiated the price target for the stock is $29.
Over the week, ANRO’s stock price is moving -69.83% down while it is -63.33% when we observe its performance for the past one month. Year-to-date it is -78.94% down and over the past year.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -7.77 beaten by the consensus estimate of -1.67 for the same. The company is expected to be releasing its next quarterly report on 2024-Aug-13, for which analysts forecasted an EPS of -0.65 while estimate for next year EPS is -2.64.
Currently, Alto Neuroscience Inc.’s total number of outstanding shares is 26.88M. Stock has a price to book (P/B) ratio of 0.65.
